Investment
Features
FeesSafety
Academy
More
Pluang+

BD completes enrollment in large trial testing Phasix™ Mesh to prevent incisional hernias after surgery

Company Fundamentals
12 Aug 2026
PRNewsWire
View Source
Bullish
pluang ai news

BD announced the completion of patient enrollment in the PREVENT trial, the first large randomized study evaluating Phasix™ Mesh for preventing incisional hernias, a common complication after abdominal surgery. The trial enrolled 477 patients across 32 sites in the US and Europe and will follow patients for up to five years to assess safety and effectiveness. Results are expected to support a regulatory submission to the FDA, potentially expanding treatment options for hernia prevention using resorbable mesh technology. This milestone advances BD's tissue regeneration strategy and innovation in surgical care.

More News (BDX)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App